Home » Consulting Services » Operational Assessments »

Operational Assessments

PHSL assists clients solve their challenging operational issues through an onsite review, analysis, and recommendations on improving specific functional areas. PHSL is typically asked to intervene when the area in question is in need of revamping and an independent outside perspective is desired. We bring deep operational experience to assess the current situation, map strategies to improve the operation, and execute on these strategies to ensure the desired results are achieved. PHSL has provided onsite leadership in turnaround situations and has assisted senior management with the recruitment and hiring of new leadership if the situation dictates. PHSL’s experience runs the gamut from PBM and Health Plan leadership, specialty pharmacy, long term care pharmacy, and Medicare Part D plans. If your organization is in need of an independent critical assessment of a challenging situation, please contact PHSL for assistance.

View our case studies related to operational assessment:

Assessment of HIPAA Processes and Procedures to Protect PHI

Manufacturer Seeks Redesign of Return Goods Policy

Nursing Home Pharmacy’s Operations and Financials Dramatically Improved

Organization Turnaround

Pharmacy Chain Inventory Management System and Financial Reporting Evaluation

PHSI Identifies $3 Million in Opportunities to Improve Gross Margin

Strategic Redesign of Corporate Structure

Technology Provider Sought to Better Serve New and Existing Clients

May 2023 Question of the Month

Which type of project(s) could you or your organization most benefit from in 2023?

Future forecast: 0%

Competitor comparison: 20%

Contract variance analysis: 20%

Historical trend analysis: 20%

Legislative/regulatory impact: 0%

Procurement cost/savings: 20%

Stakeholder program impact: 20%

April 2023 Question of the Month

In July 2022, the FDA proposed expanding the NDC to a uniform 12 numeric digit format to accommodate future needs when all options using the current formats have been exhausted. Alternative options shared by the industry have asked the FDA to consider retaining the current NDC formats and allow the use of alpha characters when all numeric options have been exhausted.

Which of the following transition types is your organization prepared for in the next 5 years?

Make the transition to alphanumeric using the current NDC formats: 70%

Make the transition to the 12-digit numeric format: 20%

Make the transition to neither option: 10%

Make the transition to either option: 0%

March 2023 Question of the Month

What information would you most like to gain from an Online Listening Assessment for a particular drug therapy or device? (Multiple selections allowed)

Prescribing & Dispensing Concerns: 25%

Competitor Comparisons: 25%

Prescribing Information Alignment: 17%

Coverage & Reimbursement: 17%

Patient Affordability: 8%

Misinformation: 8%

Disease State Concerns: 0%